The double face of fentanyl: the neuronal basis of opioid addiction

Life Sciences - May 22
Life Sciences

Scientists from the University of Geneva have discovered that fentanyl leads to the activation of two distinct cell populations in the brain, first when the drug is taken and then during withdrawal, suggesting a novel model for opioid addiction. Fentanyl is a particularly powerful synthetic opioid. Diverted from its original medical use, it has become a deadly drug responsible for three-quarters of overdose deaths in the United States.

Health - May 22

Gentler cell therapies for blood cancer

Researchers have developed an approach to -deleting- a blood system affected by leukemia while simultaneously building up a new, healthy system with donor blood stem cells. Writing in the journal Nature, the team reports on the promising results obtained in animal experiments and with human cells in the laboratory.

Chocolate that harnesses the full potential of the cocoa fruit

Agronomy & Food Science

Researchers at ETH Zurich have teamed up with the food industry to produce a whole-fruit variety of chocolate. This helps increase the value creation of cocoa farming - and is healthier.

Physics - May 22

Gamma-ray method monitors nuclear reactors safely and quickly


Scientists at EPFL have devised and tested out a new, gamma-noise method for monitoring nuclear reactors non-invasively and from a distance. The new method, tested out on EPFL's CROCUS nuclear reactor, can improve nuclear safety and treaty compliance.

Health - May 21

How immune cells recognize the abnormal metabolism of cancer cells


When cells become tumor cells, their metabolism changes fundamentally. Researchers at the University of Basel and the University Hospital Basel have now demonstrated that this change leaves traces that could provide targets for cancer immunotherapies.